Key facts
- This page summarizes Ivan Tornos's Form 4 filing for ZIMMER BIOMET HOLDINGS, INC. (ZBH).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 08 Mar 2024, 17:04.
Ivan Tornos - 06 Mar 2024 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)
- Reporting relationship
- President & CEO, Director
- Issuer ticker
- ZBH
- Reported as of
- 06 Mar 2024
- Net transaction value
- -$709,876
- SEC form
- 4
- Accepted by SEC
- 08 Mar 2024, 17:04:44 UTC
- Prior SEC filing
- 27 Feb 2024
- Next SEC filing
- 19 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew R. St. Louis, Attorney-in-Fact for Ivan Tornos (power of attorney previously filed
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ivan Tornos filed Form 4 for ZIMMER BIOMET HOLDINGS, INC. (ZBH) on 08 Mar 2024.
Change
- Previous filing in this sequence was filed on 27 Feb 2024.
- Current net transaction value: -$709,876.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZBH
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +10,270
- Change %
- +46%
- Price
- $0.000000
- Shares after
- 32,395
- Date
- 06 Mar 2024
- Ownership
- Direct
ZBH
transaction
Common Stock
Tax liability
- Transaction value
- $709,876
- Shares
- -5,642
- Change %
- -17%
- Price
- $125.82
- Shares after
- 26,753
- Date
- 06 Mar 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZBH
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -10,270
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 20,536
- Date
- 06 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,270
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").
Footnote F2
Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.
Footnote F3
One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026.